OrthoPediatrics Corp. (KIDS)
Automate Your Wheel Strategy on KIDS
With Tiblio's Option Bot, you can configure your own wheel strategy including KIDS - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowNews
OrthoPediatrics (KIDS) Upgraded to Buy: What Does It Mean for the Stock?
Published: March 03, 2026 by: Zacks Investment Research
Sentiment: Positive
OrthoPediatrics (KIDS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Read More
Wall Street Analysts See a 32.67% Upside in OrthoPediatrics (KIDS): Can the Stock Really Move This High?
Published: March 03, 2026 by: Zacks Investment Research
Sentiment: Positive
The average of price targets set by Wall Street analysts indicates a potential upside of 32.7% in OrthoPediatrics (KIDS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Read More
OrthoPediatrics to Participate in Upcoming Conferences
Published: February 27, 2026 by: GlobeNewsWire
Sentiment: Neutral
WARSAW, Ind., Feb. 27, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that it will participate in two upcoming investor conferences.
Read More
OrthoPediatrics Corp. (KIDS) Q4 2025 Earnings Call Transcript
Published: February 26, 2026 by: Seeking Alpha
Sentiment: Neutral
OrthoPediatrics Corp. (KIDS) Q4 2025 Earnings Call Transcript
Read More
OrthoPediatrics (KIDS) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Published: February 26, 2026 by: Zacks Investment Research
Sentiment: Positive
Although the revenue and EPS for OrthoPediatrics (KIDS) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Read More
OrthoPediatrics Announces Expanded Enabling Technology Market Opportunity
Published: February 03, 2026 by: GlobeNewsWire
Sentiment: Neutral
OrthoPediatrics partner iotaMotion receives FDA clearance for use of its iotaSOFT® cochlear implant insertion system in patients four years and older OrthoPediatrics partner iotaMotion receives FDA clearance for use of its iotaSOFT® cochlear implant insertion system in patients four years and older
Read More
Wall Street Analysts Think OrthoPediatrics (KIDS) Could Surge 26.45%: Read This Before Placing a Bet
Published: November 26, 2025 by: Zacks Investment Research
Sentiment: Positive
The average of price targets set by Wall Street analysts indicates a potential upside of 26.5% in OrthoPediatrics (KIDS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Read More
Wall Street Analysts Believe OrthoPediatrics (KIDS) Could Rally 41.92%: Here's is How to Trade
Published: November 10, 2025 by: Zacks Investment Research
Sentiment: Positive
The consensus price target hints at a 41.9% upside potential for OrthoPediatrics (KIDS). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Read More
OrthoPediatrics Corp. (KIDS) Q3 2025 Earnings Call Transcript
Published: October 28, 2025 by: Seeking Alpha
Sentiment: Neutral
OrthoPediatrics Corp. (NASDAQ:KIDS ) Q3 2025 Earnings Call October 28, 2025 4:30 PM EDT Company Participants David Bailey - President, CEO & Director Fred Hite - CFO, Principal Financial & Accounting Officer, COO and Director Conference Call Participants Philip Taylor - Gilmartin Group LLC David Turkaly - Citizens JMP Securities, LLC, Research Division Benjamin Haynor - Lake Street Capital Markets, LLC, Research Division Ravi Misra - Truist Securities, Inc., Research Division Presentation Operator Good afternoon, and welcome to the OrthoPediatrics Corporation Third Quarter 2025 Conference Call. [Operator Instructions] As a reminder, this call is being recorded for replay purposes.
Read More
OrthoPediatrics (KIDS) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
Published: May 07, 2025 by: Zacks Investment Research
Sentiment: Positive
The headline numbers for OrthoPediatrics (KIDS) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Read More
OrthoPediatrics (KIDS) Reports Q1 Loss, Tops Revenue Estimates
Published: May 07, 2025 by: Zacks Investment Research
Sentiment: Negative
OrthoPediatrics (KIDS) came out with a quarterly loss of $0.39 per share versus the Zacks Consensus Estimate of a loss of $0.26. This compares to loss of $0.30 per share a year ago.
Read More
OrthoPediatrics Corp. (KIDS) Q4 2024 Earnings Call Transcript
Published: March 04, 2025 by: Seeking Alpha
Sentiment: Neutral
OrthoPediatrics Corp. (NASDAQ:KIDS ) Q4 2024 Earnings Conference Call March 4, 2025 4:30 PM ET Company Participants Trip Taylor - Gilmartin Group, IR David Bailey - President and CEO Fred Hite - Chief Operating and Financial Officer Conference Call Participants Ryan Zimmerman - BTIG Rick Wise - Stifel Matthew O'Brien - Piper Sandler Joseph Conway - Needham & Company Operator Hello. And welcome to OrthoPediatrics Corporation's Fourth Quarter and Full Year 2024 Earnings Conference Call.
Read More
Compared to Estimates, OrthoPediatrics (KIDS) Q4 Earnings: A Look at Key Metrics
Published: March 04, 2025 by: Zacks Investment Research
Sentiment: Neutral
While the top- and bottom-line numbers for OrthoPediatrics (KIDS) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Read More
OrthoPediatrics (KIDS) Reports Q4 Loss, Misses Revenue Estimates
Published: March 04, 2025 by: Zacks Investment Research
Sentiment: Negative
OrthoPediatrics (KIDS) came out with a quarterly loss of $0.29 per share versus the Zacks Consensus Estimate of a loss of $0.22. This compares to loss of $0.23 per share a year ago.
Read More
About OrthoPediatrics Corp. (KIDS)
- IPO Date 2017-10-13
- Website https://www.orthopediatrics.com
- Industry Medical - Devices
- CEO David R. Bailey
- Employees 562